Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)

NCT00565851

Clinical Trial Information


Trial Number: NCT00565851 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Study ID:
GOG-0213
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00565851-D2 This dataset contains quality of life (QOL) data from trial NCT00565851 presented in PMID - 31722153.
NCT00565851-D1 This dataset contains the treatment comparison data for secondary cytoreduction before chemotherapy and chemotherapy alone in trial NCT00565851.

NCT00108745

Clinical Trial Information


Trial Number: NCT00108745 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103(IND# 70177) Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy
Study ID:
GOG-0212
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT02446600

Clinical Trial Information


Trial Number: NCT02446600 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Study ID:
NRG-GY004
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00954174

Clinical Trial Information


Trial Number: NCT00954174 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Miscellaneous
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary
Study ID:
GOG-0261
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00954174-D2 This dataset contains quality of life (QOL) data from trial NCT00954174 presented in 35007153. NCT00954174-D1 contains patient characteristics, outcome data, and adverse event data.
NCT00954174-D1 This dataset contains the data for the treatment comparison between Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in trial NCT00954174. NCT00954174-D2 contains quality-of-life data.

NCT00951496

Clinical Trial Information


Trial Number: NCT00951496 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Study ID:
GOG-0252
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT02101788

Clinical Trial Information


Trial Number: NCT02101788 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A randomized phase II/III study to assess the efficacy of trametinib (GSK 1120212) in patients with recurrent or progressive low-grade serous ovarian cancer or peritoneal cancer.
Study ID:
GOG-0281
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00262847

Clinical Trial Information


Trial Number: NCT00262847 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Study ID:
GOG-0218
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT01167712

Clinical Trial Information


Trial Number: NCT01167712 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination With Carboplatin With or Without Concurrent and Consolidation Bevacizumab (NSC #704865) in the Treatment of Primary Stage II, III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer and ACRIN 6695: Perfusion CT Imaging to Evaluate Treatment Response in Patients Participating in GOG-0262
Study ID:
GOG-0262
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT01167712-D5 There are 5 data submissions associated with PMID 26933849. This dataset contains the reason(s) for treatment delay in trial NCT01167712.
NCT01167712-D4 There are 5 data submissions associated with PMID 26933849. This dataset contains treatments administered at each cycle from NCT01167712.
NCT01167712-D3 There are 5 data submissions associated with PMID 26933849. This dataset contains the maximum grade of adverse events experienced by subjects in NCT01167712.
NCT01167712-D2 There are 5 data submissions associated with PMID 26933849. This dataset contains quality of life (QoL) data from trial NCT01167712.
NCT01167712-D1 There are 5 data submissions associated with PMID 26933849. This dataset contains the treatment comparison between dose-dense versus weekly Paclitaxel and Carboplatin in trial NCT01167712.
Subscribe to Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®